Inoue, Kayo
Tsubamoto, Hiroshi
Isono-Nakata, Roze
Sakata, Kazuko
Nakagomi, Nami
Funding for this research was provided by:
KAKENHI (JP17K11306)
Article History
Received: 26 October 2017
Accepted: 18 May 2018
First Online: 4 June 2018
Ethics approval and consent to participate
: This study was a part of a clinical trial titled ‘Prospective evaluation of the molecular effects of itraconazole as an anti-cancer agent: a window of opportunity study’, which was approved by the institutional review board of Hyogo College of Medicine (No. 282). Authors obtained written informed consent and publication consent from the patient.
: Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the editor of this journal.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.